Skip to content
10-Q

Quarterly Report

Golden Ally Lifetech Group, Inc.

0001493152-23-017483

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 12, 2023 7.41B sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$665.14K
Operating Cash Flow restated Q1 2023 · Mar 31, 2022 −$2.33M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $191.04K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $581.97K
Stockholders Equity Q1 2023 · Mar 31, 2023 $908.91K
Stockholders Equity Q1 2023 · Dec 31, 2022 $1.59M
Stockholders Equity restated Q1 2023 · Mar 31, 2022 $5.7M
Current Liabilities Q1 2023 · Mar 31, 2023 $374.74K
Current Liabilities Q1 2023 · Dec 31, 2022 $98.32K
Total Liabilities Q1 2023 · Mar 31, 2023 $387.29K
Total Liabilities Q1 2023 · Dec 31, 2022 $129.32K
Current Assets Q1 2023 · Mar 31, 2023 $1.22M
Current Assets Q1 2023 · Dec 31, 2022 $1.62M
Total Assets Q1 2023 · Mar 31, 2023 $1.3M
Total Assets Q1 2023 · Dec 31, 2022 $1.72M
Eps Basic Q1 2023 · Mar 31, 2023 $0.00
Eps Basic restated Q1 2023 · Mar 31, 2022 $0.00
Sga Expense Q1 2023 · Mar 31, 2023 $1.79M
Sga Expense Q1 2023 · Mar 31, 2022 $156.55K
Rd Expense Q1 2023 · Mar 31, 2023 $1.6K
Net Income Q1 2023 · Mar 31, 2023 −$2.43M
Net Income Q1 2023 · Mar 31, 2022 −$1.96M
Operating Income Q1 2023 · Mar 31, 2023 −$2.43M
Operating Income Q1 2023 · Mar 31, 2022 −$1.96M